French Pharma Stock News

Arkema (ENXTPA:AKE) has come into focus after releasing full year 2025 results, showing sales of €9,068 million and net income of €63 million, alongside an annual dividend announcement of €3.60 per share. See our latest analysis for Arkema. Arkema’s latest results and dividend decision come after a sharp 21.20% 1 month share price return to €61.45 and a 17.38% year to date share price gain. However, the 1 year total shareholder return of 18.76% and 5 year total shareholder return of 23.27%...

Vallourec (ENXTPA:VK) has drawn fresh attention after signing a Memorandum of Understanding with Baker Hughes, focused on integrating its Delphy underground hydrogen storage solution with Baker Hughes compression technology for green hydrogen projects. See our latest analysis for Vallourec. The recent hydrogen storage MOU sits alongside other developments, including a share buyback program and board changes involving ArcelorMittal representation. This comes during a period where Vallourec’s...

The UK's Commission on Human Medicines has issued updated recommendations on the prescribing information for Valneva's chikungunya vaccine, IXCHIQ. The changes refine restrictions on use in specific patient groups following earlier concerns about adverse events. The update affects how IXCHIQ can be used in the UK and reflects ongoing post marketing safety monitoring. For investors watching Valneva (ENXTPA:VLA), this regulatory update lands at a time when the shares trade around €4.69. The...

TotalEnergies (ENXTPA:TTE) has signed a preliminary 20 year LNG offtake agreement linked to the proposed Alaska LNG project. The company plans to purchase 2 million tons of LNG per year, with volumes targeted for customers in Asian markets. The arrangement is tied to a direct Pacific shipping route that aims to shorten transit times from Alaska to Asia. TotalEnergies is already active across the LNG value chain. This new agreement would add a North American source to its mix if the project...

Exosens (ENXTPA:EXENS) is back in the spotlight after reporting 2025 sales of €468.2 million and net income of €42.7 million, alongside new 2026 revenue guidance and a proposed €0.30 per share dividend. See our latest analysis for Exosens. The latest earnings beat, new 2026 revenue guidance and the proposed €0.30 dividend appear to be feeding into strong momentum, with a 30 day share price return of 15.99% and a 1 year total shareholder return of 151.14% at a €62.4 share price. If this kind...

Event driven interest in 2CRSI stock The Chemours Company and 2CRSI (ENXTPA:AL2SI) have signed a Joint Development Agreement focused on two phase immersion and direct to chip cooling for high density AI hardware, which ties the stock story closely to data center thermal management. See our latest analysis for 2CRSI. These cooling and AI infrastructure announcements have arrived during a period of sharp share price momentum for 2CRSI, with a 30 day share price return of 105.19% and a year to...

If you are wondering whether Orange’s share price still offers value after a strong run, you are not alone. This article will break down what the current price might be implying about the company. Orange recently closed at €17.84, with a 1 week return of a 1.7% decline, a 30 day return of 15.2% and a 1 year return of 64.8%. This naturally raises questions about how much of its potential is already reflected in the price and how risk is being priced in. Over the past few months, Orange has...

Thales (ENXTPA:HO) has released its 2026 Data Threat Report, focusing on risks linked to rapid AI adoption. The report finds that many enterprises now view AI as their top data security threat due to broad data access and limited controls. Findings highlight that current security practices often give AI systems more freedom over sensitive data than human users receive. For you as an investor or industry watcher, this matters because Thales is a major cybersecurity and digital identity...

Wondering whether Renault at €32.43 is offering value or just a value trap? This article will walk you through what the current price might be implying. Over the short term, the share price has moved by 0.8% over 7 days and 2.5% over 30 days. Yet year to date it is down 10.8% and the 1 year return sits at a 31.5% decline, with a 3 year return of 16.1% decline and a 5 year return of 9.1% decline. These mixed returns come against a backdrop of ongoing news around the global auto sector,...

Gaztransport & Technigaz (ENXTPA:GTT) has caught investor attention after its 2025 earnings release, a proposed higher cash dividend of €8.94 per share, and fresh 2026 revenue guidance in the €740 million to €780 million range. See our latest analysis for Gaztransport & Technigaz. At a share price of €192.2, recent momentum has been strong, with a 30 day share price return of 7.19% and a year to date gain of 23.76%. The 5 year total shareholder return of 240.60% points to a long term track...

Teleperformance SE has released its full-year 2025 results, reporting sales of €10,209 million and net income of €497 million, both slightly lower than the prior year, with basic earnings per share from continuing operations easing to €8.47. The simultaneous decline in both revenue and earnings raises questions about the resilience of Teleperformance’s operations just as investors focus on its longer-term AI- and automation-led plans. We’ll now examine how this recent dip in annual revenue...

Engie (ENXTPA:ENGI) has laid out a mixed picture for FY 2025 so far, with first half revenue of €38.1b and basic EPS of €1.16, against a backdrop where trailing 12 month revenue sits at €71.9b and EPS at €1.52. Looking back, revenue has moved from €37.5b in the first half of 2024 to €36.3b in the second half and then to €38.1b in the first half of 2025, while basic EPS has shifted from €0.78 to €0.88 and then to €1.16. This frames a story where investors are weighing improving profitability...

Why Carmila is on investors’ radar today Carmila (ENXTPA:CARM) has drawn attention after recent share price moves, with the stock showing positive returns over the past month and the past 3 months, prompting a closer look at its fundamentals. See our latest analysis for Carmila. Beyond the recent bounce, Carmila’s 30 day share price return of 11.6% and year to date share price return of 7.9% sit alongside a 1 year total shareholder return of 10.3%. Longer term total shareholder returns over 3...

Eutelsat Communications (ENXTPA:ETL) has completed a €1.5b senior notes offering. The company plans to use the proceeds to redeem existing notes and repay credit facilities. The transaction marks a significant step in reshaping Eutelsat Communications' debt profile. Eutelsat Communications operates in the satellite communications sector, serving video, data, and connectivity needs across different regions. For you as an investor, a large refinancing move of €1.5b is a meaningful event...

Technip Energies (ENXTPA:TE) is back in focus after securing major Engineering, Procurement, Construction and Commissioning contracts for QatarEnergy’s North Field West LNG project and the Coral Norte floating LNG project offshore Mozambique. See our latest analysis for Technip Energies. The latest QatarEnergy and Coral Norte wins arrive alongside a 1-day share price return of 4.04% and a 7-day share price return of 10.98%. The €37.6 share price sits against a 1-year total shareholder return...

Why Michelin’s Recent Share Move Has Caught Investor Attention Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) has seen its share price move in recent weeks, prompting investors to look more closely at its recent returns and fundamentals. The stock shows a 0.4% decline over the past day, alongside gains of 2.0% over the past week, around 11% over the past month, and about 21% over the past 3 months. This is drawing interest from readers tracking...

Danone has recalled certain infant formula products, with management flagging an estimated impact on first quarter sales. The CEO has publicly emphasized product safety and expressed confidence in the regulatory outlook. Management indicated conditions are normalizing in Europe and the Middle East, while operations in China remain unaffected. For investors watching ENXTPA:BN, the recall hits a sensitive part of Danone’s portfolio and comes at a time when the share price stands at €72.7...

Fnac Darty FY 2025 earnings in focus Fnac Darty (ENXTPA:FNAC) has put FY 2025 under the spotlight with first half revenue of about €4.5b and a basic EPS loss of €2.96 per share, giving investors a clear look at how its retail margins are holding up. The group has seen revenue move from €3.4b in the first half of 2024 to €4.5b in the first half of 2025, while basic EPS shifted from a loss of €2.78 to a loss of €2.96, setting the stage for a results season where the key question is how quickly...

Edenred (ENXTPA:EDEN) has reported its FY 2025 figures with second half revenue of €1.4b and basic EPS of €1.21, alongside trailing 12 month revenue of €2.7b and EPS of €2.18 that frame the latest print for investors watching the trend in earnings power. Over recent reporting periods, the company has seen revenue move from €1.34b in the second half of 2024 to €1.39b in the second half of 2025, while trailing 12 month EPS shifted from €2.07 to €2.18. This provides a clearer view of how the top...

If you are wondering whether Veolia Environnement is fairly priced or offering value at its current level, this article will walk through the key numbers that matter. The stock last closed at €35.43, with returns of 3.7% over 7 days, 13.7% over 30 days, 17.6% year to date, 30.0% over 1 year, 44.1% over 3 years and 101.1% over 5 years. These figures have likely caught the eye of investors watching the recent share price move. Recent news coverage around Veolia has focused on its position in...

Eiffage (ENXTPA:FGR) has put fresh numbers on the table for FY 2025, with first half revenue at about €12.3b, basic EPS of €3.30 and net income of €308m. This sets the tone for how the rest of the year might shape up for shareholders watching profitability. The company has seen revenue move from €11.4b in the first half of 2024 to €12.3b in the first half of 2025, while basic EPS went from €4.06 to €3.30 over the same periods. This gives investors a mixed first read on how returns are...

Altareit (ENXTPA:AREIT) has posted its FY 2025 first half results with revenue of €859.8 million and basic EPS of €4.63 loss, setting a cautious tone for investors tracking the REIT’s latest update. The company has seen revenue shift from €1.13 billion in the first half of FY 2024 to €1.48 billion in the second half of FY 2024, before landing at €859.8 million in the first half of FY 2025. Basic EPS moved from a €6.01 loss to a €28.88 loss over FY 2024 and then to a €4.63 loss in the latest...

OPmobility (ENXTPA:OPM) Posts FY 2025 First Half Results OPmobility (ENXTPA:OPM) has reported first half FY 2025 revenue of €5.3b with basic EPS of €0.63, setting the tone for how its profitability story is evolving this year. The company has seen revenue move from €5.1b and EPS of €0.49 in H2 2024 to €5.3b and EPS of €0.63 in H1 2025, compared with a prior H1 2024 reference point of €5.4b in revenue and EPS of €0.69. This gives investors a clearer view of how the top line and per share...

Bureau Veritas FY 2025 earnings snapshot Bureau Veritas (ENXTPA:BVI) has wrapped up FY 2025 with second half revenue of €3.39b and basic EPS of €0.60, alongside net income of €265.7m. These figures help frame how investors assess the latest full year picture. The company reported revenue of €3.33b and basic EPS of €0.75 in H2 2024, compared with €3.39b and €0.60 in H2 2025. Trailing twelve month revenue stands at €6.68b with EPS of €1.32, which highlights how efficiently those sales are...